Vasopressin and diabetes mellitus
Abstract
In diabetes mellitus (DM), the urine flow rate is increased, and the fluid turnover in the body is accelerated because of the glucose-induced osmotic diuresis. On the other hand, plasma vasopressin (VP) is elevated in both type 1 and type 2 DM. This elevation seems to be due to a resetting of the osmostat. A high VP level is beneficial in the short term because it limits to some extent the amount of water required for the excretion of a markedly enhanced load of osmoles (mainly glucose). However, in the long run, it may have adverse effects by favoring the developement of diabetic nephropathy. VP has been shown in normal rats to induce kidney hypertrophy, glomerular hyperfiltration, and an increase in urinary albumin excretion (features also occurring in association in the period preceding diabetic nephropathy). Moreover, VP has been shown to participate in the progression of renal failure in rats with five-sixths reduction in renal mass. In recent studies, we have shown (1) that creatinine clearance, albuminuria and renal mass increased much less during experimental DM in Brattleboro rats unable to secrete VP than in their VP-replete Long-Evans controls, and (2) that albuminuria was prevented during experimental DM in Wistar rats when a VP nonpeptidic, highly selective V2 receptor antagonist was administered chronically for 9 weeks. Taken together, these results strongly suggest that VP plays a crucial role in the onset and aggravation of the renal complications of DM. The mechanisms by which VP exerts these adverse V2-dependent effects are not yet elucidated. They are most likely indirect and may involve several intermediate steps comprising VP-induced changes in the composition of the tubular fluid in the loop of Henle (due to solute recycling in the renal medulla associated with improved concentrating activity of the kidney), inhibition of the tubuloglomerular feedback control of glomerular function, and alterations in glomerular hemodynamics by the intrarenal renin-angiotensin system.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Vasopressin receptors are expressed in hepatocytes and pancreatic islets.
“A causal link between vasopressin and glucose homeostasis is plausible because vasopressin induces gluconeogenesis in the rat liver and transiently increases glycemia in healthy humans and because vasopressin receptors are expressed in hepatocytes and pancreatic islets (2–9).”
From Low Water Intake and Risk for New-Onset Hyperglycemia (2011) · cites this paper as [3]
A causal link between vasopressin and glucose homeostasis is plausible.
“A causal link between vasopressin and glucose homeostasis is plausible because vasopressin induces gluconeogenesis in the rat liver and transiently increases glycemia in healthy humans and because vasopressin receptors are expressed in hepatocytes and pancreatic islets (2–9).”
From Low Water Intake and Risk for New-Onset Hyperglycemia (2011) · cites this paper as [3]
Vasopressin transiently increases glycemia in healthy humans.
“A causal link between vasopressin and glucose homeostasis is plausible because vasopressin induces gluconeogenesis in the rat liver and transiently increases glycemia in healthy humans and because vasopressin receptors are expressed in hepatocytes and pancreatic islets (2–9).”
From Low Water Intake and Risk for New-Onset Hyperglycemia (2011) · cites this paper as [3]
Vasopressin induces gluconeogenesis in the rat liver.
“A causal link between vasopressin and glucose homeostasis is plausible because vasopressin induces gluconeogenesis in the rat liver and transiently increases glycemia in healthy humans and because vasopressin receptors are expressed in hepatocytes and pancreatic islets (2–9).”
From Low Water Intake and Risk for New-Onset Hyperglycemia (2011) · cites this paper as [3]
Cites
The Regulation of Vasopressin Function in Health and Disease
Robertson, G. L. (1977) · Elsevier eBooks · doi:10.1016/b978-0-12-571133-3.50015-5 · Cited by 375 · see citing works
Gal, C. S., Lacour, C., Valette, G., Garcia, G., Foulon, L., Galindo, G., Bankir, L., Pouzet, B., Guillon, G., Barberis, C., et al. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119098 · Cited by 249 · see citing works
Self-citationPlasma Amino Acid Levels in Diabetic Ketoacidosis
Felig, P., Marliss, E. B., Ohman, J. L., & Cahill, G. F. (1970) · Diabetes · doi:10.2337/diab.19.10.727 · Cited by 242 · see citing works
Urinary concentrating ability: insights from comparative anatomy
Bankir, L., & de Rouffignac, C. (1985) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1985.249.6.r643 · Cited by 227 · see citing works
Self-citationEffect of water intake on the progression of chronic renal failure in the 5/6 nephrectomized rat
Bouby, N., Bachmann, S., Bichet, D. G., & Bankir, L. (1990) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1990.258.4.f973 · Cited by 182 · see citing works
Self-citationPlasma Vasopressin in Uncontrolled Diabetes Mellitus
Zerbe, R. L., Vinicor, F., & Robertson, G. L. (1979) · Diabetes · doi:10.2337/diab.28.5.503 · Cited by 158 · see citing works
Bardoux, P., Martin, H., Ahloulay, M., Schmitt, F., Bouby, N., Trinh-Trang-Tan, M.-M., & Bankir, L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.18.10397 · Cited by 138 · see citing works
Self-citationVasopressin increases glomerular filtration rate in conscious rats through its antidiuretic action.
Bouby, N., Ahloulay, M., Nsegbe, E., Déchaux, M., Schmitt, F., & Bankir, L. (1996) · Journal of the American Society of Nephrology · doi:10.1681/asn.v76842 · Cited by 116 · see citing works
Self-citationTHE EFFECT OF VASOPRESSIN INFUSION ON GLUCOSE METABOLISM IN MAN
SPRUCE, B. A., MCCULLOCH, A. J., BURD, J., ØRSKOV, H., HEATON, A., BAYLIS, P. H., & ALBERTI, K. G. M. M. (1985) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1985.tb00145.x · Cited by 114 · see citing works
Nicotine-Stimulated Release of Neurophysin and Vasopressin in Humans
Husain, M., FRANTZ, A. G., Ciarochi, F. F., & ROBINSON, A. G. (1975) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-41-6-1113 · Cited by 114 · see citing works
Direct and indirect cost of urea excretion
Bankir, L., Bouby, N., Trinh‐Trang‐Tan, M., Ahloulay, M., & Promeneur, D. (1996) · Kidney International · doi:10.1038/ki.1996.232 · Cited by 88 · see citing works
Self-citationDunning, B. E., Moltz, J. H., & Fawcett, C. P. (1984) · Peptides · doi:10.1016/0196-9781(84)90109-8 · Cited by 85 · see citing works
Zerbe, R. L., Miller, J. Z., & Robertson, G. L. (1991) · PubMed · Cited by 84 · see citing works
Contribution of vasopressin to progression of chronic renal failure: Study in Brattleboro rats
Bouby, N., Hassler, C., & Bankir, L. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00330-6 · Cited by 78 · see citing works
Self-citationTubuloglomerular feedback: New concepts and developments
Schnermann, J. B., Traynor, T. R., Yang, T., et al. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.06708.x · Cited by 78 · see citing works
Bankir, L., & Kriz, W. (1995) · Kidney International · doi:10.1038/ki.1995.2 · Cited by 72 · see citing works
Self-citationVasopressin in Rats With Genetic and Streptozocin-Induced Diabetes
Brooks, D. P., Nutting, D. F., Crofton, J. T., & Share, L. (1989) · Diabetes · doi:10.2337/diab.38.1.54 · Cited by 69 · see citing works
EVIDENCE IN MAN THAT CIGARETTE SMOKING INDUCES VASOPRESSIN RELEASE VIA AN AIRWAY-SPECIFIC MECHANISM
Rowe, J. W., Kilgore, A., & Robertson, G. L. (1980) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-51-1-170 · Cited by 69 · see citing works
Influence of vasopressin on renal hemodynamics in conscious Brattleboro rats
Gellai, M., Silverstein, J. H., Hwang, J. C., Larochelle, F. T., & Valtin, H. (1984) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1984.246.6.f819 · Cited by 67 · see citing works
Effect of Endogenous Insulin on Human Amino Acid Metabolism
Zinneman, H. H., Nuttall, F. Q., & Goetz, F. C. (1966) · Diabetes · doi:10.2337/diab.15.1.5 · Cited by 65 · see citing works
Berger, M., Zimmermann-Telschow, H., Berchtold, P., et al. (1978) · Metabolism · doi:10.1016/0026-0495(78)90214-7 · Cited by 63 · see citing works
Sugiura, T., Yamauchi, A., Kitamura, H., Matsuoka, Y., Horio, M., Imai, E., & Hori, M. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00443.x · Cited by 61 · see citing works
Influence of glucagon on GFR and on urea and electrolyte excretion: direct and indirect effects
Ahloulay, M., Dechaux, M., Laborde, K., & Bankir, L. (1995) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1995.269.2.f225 · Cited by 59 · see citing works
Self-citationMetabolic actions of vasopressin, glucagon and adrenalin in the intact rat
HEMS, D., WHITTON, P., & MA, G. (1975) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(75)90294-9 · Cited by 58 · see citing works
Actions of neurohypophysial peptides on pancreatic hormone release
Dunning, B. E., Moltz, J. H., & Fawcett, C. P. (1984) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1984.246.1.e108 · Cited by 58 · see citing works
Effect of insulin on osmoregulation of vasopressin
Vokes, T. P., Aycinena, P., & Robertson, G. L. (1987) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1987.252.4.e538 · Cited by 58 · see citing works
Influence of the level of hydration on the renal response to a protein meal
Hadj‐Aïssa, A., Bankir, L., Fraysse, M., Bichet, D. G., Laville, M., Zech, P. Y., & Pozet, N. (1992) · Kidney International · doi:10.1038/ki.1992.406 · Cited by 58 · see citing works
Self-citationAquaretic effects of the nonpeptide V2 antagonist OPC-31260 in hydropenic humans
Shimizu, K. (1995) · Kidney International · doi:10.1038/ki.1995.287 · Cited by 52 · see citing works
Factors contributing to the degree of polyuria in a patient with poorly controlled diabetes mellitus
Spira, A. E., Gowrishankar, M., & Halperin, M. L. (1997) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(97)90089-5 · Cited by 47 · see citing works
Plasma Arginine Vasopressin in diabetic ketoacidosis
Walsh, C. H., Baylis, P. H., & Malins, J. M. (1979) · Diabetologia · doi:10.1007/bf01225456 · Cited by 47 · see citing works
Regulation of plasma vasopressin in insulin-dependent diabetes mellitus
Zerbe, R. L., Vinicor, F., & Robertson, G. L. (1985) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1985.249.3.e317 · Cited by 47 · see citing works
Ahloulay, M., Déchaux, M., Hassler, C., Bouby, N., & Bankir, L. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119035 · Cited by 45 · see citing works
Self-citationCell Ca2+ response to luminal vasopressin in cortical collecting tubule principal cells
Ikeda, M., Yoshitomi, K., Imai, M., & Kurokawa, K. (1994) · Kidney International · doi:10.1038/ki.1994.107 · Cited by 44 · see citing works
Osmoregulation of Plasma Vasopressin in Diabetes Mellitus with Sustained Hyperglycemia
Iwasaki, Y., Kondo, K., Murase, T., et al. (1996) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.1996.05124.x · Cited by 43 · see citing works
Poulsen, P. L., Ebbehøj, E., Hansen, K. W., & MOGENSEN, C. (1998) · American Journal of Hypertension · doi:10.1016/s0895-7061(98)00115-0 · Cited by 43 · see citing works
Characterization of receptors mediating AVP- and OT-induced glucagon release from the rat pancreas
Yibchok‐anun, S., Cheng, H., Heine, P. A., & Hsu, W. H. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.277.1.e56 · Cited by 42 · see citing works
Chiodera, P., Volpi, R., Capretti, L., Speroni, G., Necchi‐Ghiri, S., Caffarri, G., Colla, R., & Coiro, V. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.1470945.x · Cited by 40 · see citing works
van Buren, T., Vleeming, W., Krutzen, M. M., et al. (1998) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/pl00005309 · Cited by 40 · see citing works
Plasma Amino Acids in Relation to Metabolic Control in Insulin‐Dependent Diabetic Children
Hagenfeldt, L., Dahlquist, G. G., & Persson, B. (1989) · Acta Paediatrica · doi:10.1111/j.1651-2227.1989.tb11070.x · Cited by 38 · see citing works
Osmoregulation of thirst and vasopressin secretion in insulin-dependent diabetes mellitus
Thompson, C. J., Davis, S. N., Butler, P. C., et al. (1988) · Clinical Science · doi:10.1042/cs0740599 · Cited by 35 · see citing works
Changes in plasma and urinary amino acid levels during diabetic ketoacidosis in children
Szabó, A., Kenesei, É., Körner, A., et al. (1991) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(91)90085-r · Cited by 35 · see citing works
Vasopressin and urinary concentrating activity in diabetes mellitus.
Ahloulay, M., Schmitt, F., Déchaux, M., & Bankir, L. (1999) · PubMed · Cited by 33 · see citing works
Self-citationPedersen, M. M., Christiansen, J. S., Pedersen, E. B., et al. (1992) · Clinical Science · doi:10.1042/cs0830445 · Cited by 31 · see citing works
Kamoi, K., Ishibashi, M., & YAMAJI, T. (1991) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(05)80033-6 · Cited by 30 · see citing works
Almdal, T., & Vilstrup, H. (1988) · Diabetologia · doi:10.1007/bf00277487 · Cited by 26 · see citing works
Plasma and neurohypophyseal content of vasopressin in diabetes mellitus.
Fujisawa, I., Murakami, N., Furuto-Kato, S., et al. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.8.8768834 · Cited by 26 · see citing works
Constrictor responses of the rat basilar artery during diabetes mellitus
Mayhan, W. G. (1998) · Brain Research · doi:10.1016/s0006-8993(97)01387-5 · Cited by 26 · see citing works
Pressor sensitivities to vasopressin, angiotensin II, or methoxamine in diabetic rats
Hebden, R. A., Bennett, T. M., & Gardiner, S. M. (1987) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1987.253.5.r726 · Cited by 26 · see citing works
Yibchok‐anun, S., & Hsu, W. H. (1998) · Life Sciences · doi:10.1016/s0024-3205(98)00463-9 · Cited by 25 · see citing works
Tallroth, G., Ryding, E., Ekman, R., et al. (1992) · PubMed · Cited by 24 · see citing works
Osmolal effects on vasopressin secretion in the streptozotocin-diabetic rat
Itallie, C. M. V., & Fernstrom, J. D. (1982) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1982.242.6.e411 · Cited by 22 · see citing works
Dunning, B. E., Verbalis, J. G., & Fawcett, C. P. (2008) · Neuroendocrinology · doi:10.1159/000124206 · Cited by 20 · see citing works
Nishikawa, T., Omura, M., Iizuka, T., et al. (1996) · PubMed · Cited by 19 · see citing works
Granda, T. G., Velasco, A., & Rausch, A. (1998) · Life Sciences · doi:10.1016/s0024-3205(98)00394-4 · Cited by 19 · see citing works
Down-Regulation of Vasopressin VlA Receptor mRNA in Diabetes Mellitus in the Rat
Phillips, P. A., Risvanis, J., Hutchins, A., et al. (1995) · Clinical Science · doi:10.1042/cs0880671 · Cited by 18 · see citing works
Rosenlund, B. L. (1993) · Biochemical Medicine and Metabolic Biology · doi:10.1006/bmmb.1993.1038 · Cited by 16 · see citing works
Pijl, H., van Loon, B. J. P., Toornvliet, A. C., Radder, J. K., Onkenhout, W., Frölich, M., & Meinders, A. E. (1994) · Metabolism · doi:10.1016/0026-0495(94)90208-9 · Cited by 15 · see citing works
Diabetes mellitus in Brattleboro rats: cardiovascular, fluid, and electrolyte status
Tomlinson, K., Gardiner, S. M., & Bennett, T. M. (1989) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1989.256.6.r1279 · Cited by 13 · see citing works
Yamada, K., Nakano, H., Nishimura, M., et al. (1995) · Journal of Diabetes and its Complications · doi:10.1016/1056-8727(95)80033-b · Cited by 10 · see citing works
Platelet Aggregation and Vasopressin Receptors in Patients with Diabetes Mellitus
Thibonnier, M., & Woloschak, M. (1988) · Experimental Biology and Medicine · doi:10.3181/00379727-188-42720 · Cited by 9 · see citing works
Trevisan, R., Marescotti, C., Avogaro, A., et al. (1989) · PubMed · Cited by 9 · see citing works
Pharmacological Profile of VP-343, a Novel Selective Vasopressin V2 Receptor Antagonist, in Rats.
Naito, A., OHTAKE, Y., Hasegawa, H., et al. (2000) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.23.182 · Cited by 8 · see citing works
Interactive computerized microscopy as a tool for quantifying vascular remodelling
Méchaly, I., Krośniak, M., Azay, J., Cassanas, G., Roque, C., Cahard, D., Serrano, J., & Cros, G. H. (1999) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(99)00021-0 · Cited by 8 · see citing works
Suppressive Effect of Vasopressin on Ketosis in Diabetic Rats
Harano, A., Hidaka, H., Kojima, H., et al. (1992) · Hormone and Metabolic Research · doi:10.1055/s-2007-1003241 · Cited by 6 · see citing works
Response of plasma arginine vasopressin to nicotine in normal man
Goldsmith, S. R., Katz, A., & Crooks, P. A. (1988) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1988.182 · Cited by 6 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Vasopressin: a novel target for the prevention and retardation of kidney disease?
Bankir, L., Bouby, N., & Ritz, E. (2013) · Nature Reviews Nephrology · doi:10.1038/nrneph.2013.22 · Cited by 214 · see citing works
Self-citationLow Water Intake and Risk for New-Onset Hyperglycemia
Roussel, R., Fezeu, L., Bouby, N., Balkau, B., Lantieri, O., Alhenc-Gelas, F., Marre, M., Bankir, L., & for the D.E.S.I.R. Study Group (2011) · Diabetes Care · doi:10.2337/dc11-0652 · Cited by 165 · see citing works
Self-citationBardoux, P. (2003) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/18.3.497 · Cited by 136 · see citing works
Self-citationPlasma Copeptin and Renal Outcomes in Patients With Type 2 Diabetes and Albuminuria
Velho, G., Bouby, N., Hadjadj, S., Matallah, N., Mohammedi, K., Fumeron, F., Potier, L., Bellili-Munoz, N., Taveau, C., Alhenc-Gelas, F., et al. (2013) · Diabetes Care · doi:10.2337/dc13-0683 · Cited by 89 · see citing works
Self-citationFolny, V., Raufaste, D., Lukovic, L., Pouzet, B., Rochard, P., Pascal, M., & Serradeil-Le Gal, C. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00148.2003 · Cited by 61 · see citing works
Yi, S. S., Hwang, I. K., Kim, Y. N., Kim, I. Y., Pak, S.-I., Lee, I. S., Seong, J. K., & Yoon, Y. S. (2008) · Neurochemical Research · doi:10.1007/s11064-007-9519-2 · Cited by 30 · see citing works
- Authors
- Bankir, L., Bardoux, P., & Ahloulay, M.
- Affiliations
- Inserm (FR)
- ORCID
- Bankir, Lise
- Venue
- Nephron
- Publisher
- S. Karger AG
- Published
- 2001
- Volume
- 87
- Issue
- 1
- Pages
- 8-18
- ISSN
- 1660-8151 (ISSN-L)
- 2235-3186
- OpenAlex
- W2037060198
- Cited by
- 110
- References
- 66
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 3 · 2023: 8 · 2022: 2 · 2021: 2 · 2020: 4 · 2019: 5 · 2018: 8 · 2017: 8 · 2016: 8 · 2015: 5 · 2014: 3 · 2013: 5 · 2012: 3
- FWCI
- 3.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Nephron journals/Nephron journals (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Institut National de la Santé et de la Recherche Médicale
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Electrolyte and hormonal disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion Transport and Channel Regulation
- Keywords
- vasopressin, diabetes mellitus, diabetic nephropathy, osmotic diuresis, vasopressin V2 receptor antagonist, albuminuria, renal hypertrophy, glomerular hyperfiltration, tubuloglomerular feedback, intrarenal renin-angiotensin system, loop of Henle, Brattleboro rats, Long-Evans rats
- MeSH terms
- Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Humans, Vasopressins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review